207 related articles for article (PubMed ID: 38568974)
1. Precision proteoform design for 4R tau isoform selective templated aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger MT; Sclafani OR; Fu V; Beckett ER; Vigers M; Buée L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320456121. PubMed ID: 38568974
[TBL] [Abstract][Full Text] [Related]
2. Precision Proteoform Design for 4R Tau Isoform Selective Templated Aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger M; Sclafani O; Fu V; Vigers M; Buee L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
bioRxiv; 2023 Nov; ():. PubMed ID: 37693456
[TBL] [Abstract][Full Text] [Related]
3. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement.
Vigers MP; Lobo S; Najafi S; Dubose A; Tsay K; Ganguly P; Longhini AP; Jin Y; Buratto SK; Kosik KS; Shell MS; Shea JE; Han S
bioRxiv; 2023 Nov; ():. PubMed ID: 38077065
[TBL] [Abstract][Full Text] [Related]
4. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
[TBL] [Abstract][Full Text] [Related]
6. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
7. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
Kraus A; Saijo E; Metrick MA; Newell K; Sigurdson CJ; Zanusso G; Ghetti B; Caughey B
Acta Neuropathol; 2019 Apr; 137(4):585-598. PubMed ID: 30570675
[TBL] [Abstract][Full Text] [Related]
8. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
[TBL] [Abstract][Full Text] [Related]
9. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
10. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
11. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
[TBL] [Abstract][Full Text] [Related]
12. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
13. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
14. Three repeat isoforms of tau inhibit assembly of four repeat tau filaments.
Adams SJ; DeTure MA; McBride M; Dickson DW; Petrucelli L
PLoS One; 2010 May; 5(5):e10810. PubMed ID: 20520830
[TBL] [Abstract][Full Text] [Related]
15. Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons.
Capano LS; Sato C; Ficulle E; Yu A; Horie K; Kwon JS; Burbach KF; Barthélemy NR; Fox SG; Karch CM; Bateman RJ; Houlden H; Morimoto RI; Holtzman DM; Duff KE; Yoo AS
Cell Stem Cell; 2022 Jun; 29(6):918-932.e8. PubMed ID: 35659876
[TBL] [Abstract][Full Text] [Related]
16. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
17. Structures of filaments from Pick's disease reveal a novel tau protein fold.
Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M
Nature; 2018 Sep; 561(7721):137-140. PubMed ID: 30158706
[TBL] [Abstract][Full Text] [Related]
18. Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
Woerman AL; Aoyagi A; Patel S; Kazmi SA; Lobach I; Grinberg LT; McKee AC; Seeley WW; Olson SH; Prusiner SB
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8187-E8196. PubMed ID: 27911827
[TBL] [Abstract][Full Text] [Related]
19. Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells.
Annadurai N; Hrubý J; Kubíčková A; Malina L; Hajdúch M; Das V
Biochem Biophys Res Commun; 2023 Apr; 653():102-105. PubMed ID: 36863211
[TBL] [Abstract][Full Text] [Related]
20. Fluent molecular mixing of Tau isoforms in Alzheimer's disease neurofibrillary tangles.
Dregni AJ; Duan P; Xu H; Changolkar L; El Mammeri N; Lee VM; Hong M
Nat Commun; 2022 May; 13(1):2967. PubMed ID: 35624093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
